Adenocarcinoma of Colon Completed Phase 3 Trials for Fluorouracil (DB00544)

Also known as: Adenocarcinoma Colon / Colon Adenocarcinoma / Adenocarcinoma of the Colon

Indication	Status	Phase
DBCOND0060083 (Adenocarcinoma of Colon)	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00096278	Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer	Treatment	Bevacizumab (DB00112) Calcium (DB01373) Fluorouracil (DB00544) Leucovorin (DB00650) Levoleucovorin (DB11596) Oxaliplatin (DB00526)
NCT00025337	Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated	Treatment	Bevacizumab (DB00112) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00079274	Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer	Treatment	Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00003835	Combination Chemotherapy in Treating Patients With Stage III Colon Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT00003873	Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer	Treatment	Eniluracil (DB03516) Fluorouracil (DB00544)